STEQEYMA® (ustekinumab-stba) is Celltrion’s biosimilar to STELARA® (ustekinumab), which was launched on March 12, 2025 Celltrion’s adalimumab-aaty was previously added to the Costco Member Prescription Program in August 2024 JERSEY CITY, N.J., March 27, 2025 /PRNewswire/ — Celltrion, Inc….
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.